VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AIMDAinos, Inc.
$1.92$9M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AIMD logoAinos, Inc.(AIMD)Earnings, Financials & Key Ratios

AIMD•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryDiagnostics and Omics Tools
AboutAinos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.Show more
  • Revenue$124K+499.0%
  • EBITDA-$9M-1.9%
  • Net Income-$15M+0.6%
  • EPS (Diluted)-3.46-121.8%
  • Gross Margin-3767.2%-2350.6%
  • EBITDA Margin-7418.23%+83.0%
  • Operating Margin-11268.32%+83.1%
  • Net Margin-11897.04%+83.4%
  • ROE-128%-72.1%

AIMD Key Insights

Ainos, Inc. (AIMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 49.6%
  • ✓Share count reduced 55.1% through buybacks
  • ✓Trading at only 1.1x book value

✗Weaknesses

  • ✗Profits declining 59.1% over 5 years
  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AIMD posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AIMD Price & Volume

Ainos, Inc. (AIMD) stock price & volume — 10-year historical chart

Loading chart...

AIMD Growth Metrics

Ainos, Inc. (AIMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years51.3%
5 Years49.61%
3 Years-67.2%
TTM-82.95%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM6%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM98.61%

Return on Capital

10 Years-149.32%
5 Years-59.58%
3 Years-51.07%
Last Year-62.66%

AIMD Recent Earnings

Ainos, Inc. (AIMD) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.41
—
Rev
—
—
Q2 2026
Mar 30, 2026
Metric
Actual
Est
EPS
$0.85
—
Rev
$11,120
—
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.64
—
Rev
$2,167
—
Q3 2025
Aug 13, 2025
Metric
Actual
Est
EPS
$0.99
—
Rev
$4,663
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.41
—
Q2 2026Mar 30, 2026
$0.85
$11,120
Q4 2025Nov 13, 2025
$0.64
$2,167
Q3 2025Aug 13, 2025
$0.99
$4,663
Based on last 12 quarters of dataView full earnings history →

AIMD Peer Comparison

Ainos, Inc. (AIMD) competitors in Diagnostics and Omics Tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AEYE logoAEYEAudioEye, Inc.Direct Competitor78.83M6.31-25.2414.52%-9.05%-70.95%2.75
XTLB logoXTLBXTL Biopharmaceuticals Ltd.Direct Competitor279.46K2.54-0.26-227.72%-25.53%0.03
SABS logoSABSSAB Biotherapeutics, Inc.Direct Competitor214.23M4.00-5.06-100%-0.29%0.04
NNOX logoNNOXNano-X Imaging Ltd.Direct Competitor109.19M1.67-1.8413.91%-452.82%-35.55%0.04
INVA logoINVAInnoviva, Inc.Product Competitor1.66B22.496.8218.52%118.91%47.59%0.23
SENS logoSENSSenseonics Holdings, Inc.Product Competitor281.69M6.74-4.0656.89%-214.16%-130%0.68
ILMN logoILMNIllumina, Inc.Supply Chain24.6B161.9329.71-0.78%19.43%32.84%0.94
TMO logoTMOThermo Fisher Scientific Inc.Supply Chain172.66B464.6126.193.91%15.18%13.23%0.76

Compare AIMD vs Peers

Ainos, Inc. (AIMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AEYE

Most directly comparable listed peer for AIMD.

Scale Benchmark

vs TMO

Larger-name benchmark to compare AIMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs AEYE, XTLB, SABS, NNOX

AIMD Income Statement

Ainos, Inc. (AIMD) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
250.93K77.72K11.73K16.56K594.56K3.52M122.11K20.73K124.16K18.11K
Revenue Growth %
--69.03%-84.91%41.19%3489.71%491.97%-96.53%-83.02%498.95%-82.95%
Cost of Goods Sold
60.32K64.88K8.77K11.28K184.18K2.11M375.85K52.59K4.8M4.78M
COGS % of Revenue
24.04%83.47%74.78%68.09%30.98%60.07%307.79%253.73%3867.2%-
Gross Profit
190.61K▲ 0%
12.85K▼ 93.3%
2.96K▼ 77.0%
5.29K▲ 78.6%
410.38K▲ 7663.6%
1.41M▲ 242.4%
-253.73K▼ 118.1%
-31.87K▲ 87.4%
-4.68M▼ 14577.8%
-4.76M▲ 0%
Gross Margin %
75.96%16.53%25.22%31.91%69.02%39.93%-207.79%-153.73%-3767.2%-26296.83%
Gross Profit Growth %
834.37%-93.26%-76.97%78.64%7663.56%242.45%-118.05%87.44%-14577.84%-
Operating Expenses
770.38K1.35M1.58M1.45M4.28M15.38M12.95M13.81M9.31M8.35M
OpEx % of Revenue
307.01%1733.73%13497.33%8728.62%719.49%437.02%10607.2%66618.45%7501.12%-
Selling, General & Admin
770.38K1.31M1.53M1.45M2.36M8.54M5.64M5.4M1.56M1.82M
SG&A % of Revenue
307.01%1691.8%13049.71%8726.27%396.45%242.51%4614.84%26028.34%1259.21%-
Research & Development
032.59K52.51K3891.92M6.85M7.32M8.41M7.75M6.53M
R&D % of Revenue
-41.93%447.62%2.35%323.03%194.51%5992.36%40590.11%6241.91%-
Other Operating Expenses
0000000001
Operating Income
-579.76K▲ 0%
-1.33M▼ 130.2%
-1.58M▼ 18.4%
-1.44M▲ 8.9%
-3.87M▼ 168.5%
-13.98M▼ 261.4%
-13.21M▲ 5.5%
-13.84M▼ 4.8%
-13.99M▼ 1.1%
-13.11M▲ 0%
Operating Margin %
-231.05%-1717.2%-13472.11%-8696.7%-650.47%-397.09%-10814.99%-66772.17%-11268.32%-72393.48%
Operating Income Growth %
13.09%-130.21%-18.41%8.86%-168.49%-261.38%5.51%-4.81%-1.08%-
EBITDA
-539.77K-1.28M-1.56M-1.43M-1.82M-9.16M-8.34M-9.04M-9.21M-8.33M
EBITDA Margin %
-215.11%-1644.9%-13282.52%-8607.96%-306.61%-260.33%-6825.98%-43607.93%-7418.23%-46017.5%
EBITDA Growth %
15.81%-136.86%-21.88%8.5%-27.86%-402.61%9.03%-8.45%-1.89%8.48%
D&A (Non-Cash Add-back)
39.99K56.19K22.24K14.7K2.04M4.81M4.87M4.8M4.78M4.78M
EBIT
-579.76K-1.33M-1.58M-1.44M-3.87M-13.95M-13.63M-14.25M-13.99M-13.11M
Net Interest Income
-37.61K-3.96K-885-10.19K-18.69K-53.53K-144.19K-616.47K-711.9K-708.33K
Interest Income
0000000000
Interest Expense
37.61K3.96K88510.19K18.69K53.53K144.19K616.47K711.9K708.33K
Other Income/Expense
-37.61K-3.96K-885-10.19K-5.09K-30.48K-563.35K-1.02M-779.8K-832.81K
Pretax Income
-617.38K▲ 0%
-1.34M▼ 116.8%
-1.58M▼ 18.1%
-1.45M▲ 8.3%
-3.87M▼ 167.0%
-14.01M▼ 261.7%
-13.77M▲ 1.7%
-14.86M▼ 7.9%
-14.77M▲ 0.6%
-13.94M▲ 0%
Pretax Margin %
-246.04%-1722.3%-13479.65%-8758.21%-651.32%-397.96%-11276.33%-71698.4%-11896.4%-76991.83%
Income Tax
000016.14K0800800800800
Effective Tax Rate %
0%0%0%0%-0.42%0%-0.01%-0.01%-0.01%-0.01%
Net Income
-617.38K▲ 0%
-1.34M▼ 116.8%
-1.58M▼ 18.2%
-1.45M▲ 8.3%
-3.89M▼ 168.1%
-14.01M▼ 260.2%
-13.77M▲ 1.7%
-14.86M▼ 7.9%
-14.77M▲ 0.6%
-13.94M▲ 0%
Net Margin %
-246.04%-1722.3%-13487.2%-8758.21%-654.04%-397.96%-11276.98%-71702.26%-11897.04%-76996.25%
Net Income Growth %
7.85%-116.83%-18.19%8.32%-168.07%-260.19%1.69%-7.93%0.62%6%
Net Income (Continuing)
-617.38K-1.34M-1.58M-1.45M-3.89M-14.01M-13.77M-14.86M-14.77M-13.94M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.41▲ 0%
-0.56▼ 36.6%
-0.74▼ 32.1%
-2.69▼ 263.5%
-2.59▲ 3.7%
-5.14▼ 98.5%
-3.36▲ 34.6%
-1.56▲ 53.6%
-3.46▼ 121.8%
-2.31▲ 0%
EPS Growth %
18%-36.59%-32.14%-263.51%3.72%-98.46%34.63%53.57%-121.79%98.61%
EPS (Basic)
-0.41-0.56-0.74-2.69-2.59-5.14-3.36-1.56-3.46-
Diluted Shares Outstanding
1.51M2.38M2.15M543.08K1.51M2.73M4.1M9.5M4.27M6.03M
Basic Shares Outstanding
1.51M2.38M2.15M543.08K1.51M2.73M4.1M9.5M4.27M6.03M
Dividend Payout Ratio
----------

AIMD Balance Sheet

Ainos, Inc. (AIMD) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
2.08M1.3M445.29K76.41K2.22M2.85M2.47M4.34M1.14M3.52M
Cash & Short-Term Investments
1.98M1.28M409.04K22.25K1.75M1.85M1.89M3.89M417.35K2.84M
Cash Only
1.98M1.28M409.04K22.25K1.75M1.85M1.89M3.89M417.35K2.84M
Short-Term Investments
0000000000
Accounts Receivable
00-32.12K00201.55K455562223
Days Sales Outstanding
-----20.91.360.990.061.48
Inventory
22.67K04.13K3.02K0595.22K167.59K143.76K295.56K315.64K
Days Inventory Outstanding
137.16-171.8997.88-102.76162.76997.6422.4717.91
Other Current Assets
026.58K32.12K0466.2K195.79K419.52K301.08K425.86K362.53K
Total Non-Current Assets
209.38K160.47K151.33K183.88K38.6M34.26M29.37M24.48M19.73M18.56M
Property, Plant & Equipment
27K14.01K5.07K3.25K1.19M1.38M876.57K559.64K343.28K290.08K
Fixed Asset Turnover
9.29x5.55x2.31x5.10x0.50x2.56x0.14x0.04x0.36x0.05x
Goodwill
0000000000
Intangible Assets
182.39K146.46K146.26K180.63K37.33M32.81M28.28M23.75M19.23M18.11M
Long-Term Investments
0000000000
Other Non-Current Assets
00-151.33K087.57K80.68K208.83K174.42K163.03K161.06K
Total Assets
2.29M▲ 0%
1.46M▼ 36.2%
596.63K▼ 59.2%
260.29K▼ 56.4%
40.82M▲ 15583.3%
37.11M▼ 9.1%
31.84M▼ 14.2%
28.82M▼ 9.5%
20.87M▼ 27.6%
22.08M▲ 0%
Asset Turnover
0.11x0.05x0.02x0.06x0.01x0.09x0.00x0.00x0.01x0.00x
Asset Growth %
395.78%-36.19%-59.24%-56.37%15583.34%-9.1%-14.19%-9.49%-27.58%-104.18%
Total Current Liabilities
1.82M733.62K753.31K1.1M30.59M2.47M1.34M3.95M1.08M6.35M
Accounts Payable
159.3K115.31K208.73K145.57K000000
Days Payables Outstanding
964648.758.69K4.71K------
Short-Term Debt
886.48K513.36K444.58K953K3.59M1.26M42K3M02M
Deferred Revenue (Current)
000000112.56K106.33K350K350K
Other Current Liabilities
777.26K104.95K100K-145.57K000004.35M
Current Ratio
1.14x1.78x0.59x0.07x0.07x1.15x1.85x1.10x1.06x0.55x
Quick Ratio
1.13x1.78x0.59x0.07x0.07x0.91x1.72x1.06x0.78x0.50x
Cash Conversion Cycle
---------19.39
Total Non-Current Liabilities
000030.25K8.1K6.06M9.35M12.23M10.04M
Long-Term Debt
0000005.92M9M11M9M
Capital Lease Obligations
000030.25K8.1K0000
Deferred Tax Liabilities
0000000000
Other Non-Current Liabilities
000000135.83K348.94K1.23M1.04M
Total Liabilities
1.82M733.62K753.31K1.1M30.63M2.48M7.39M13.3M13.31M16.39M
Total Debt
886.48K513.36K444.58K953K3.62M1.27M5.96M12M11M11M
Net Debt
-1.09M-763.3K35.54K930.76K1.87M-584.74K4.08M8.11M10.58M8.16M
Debt / Equity
1.88x0.70x--0.36x0.04x0.24x0.77x1.45x1.93x
Debt / EBITDA
----------1.32x
Net Debt / EBITDA
----------0.98x
Interest Coverage
-15.41x-336.78x-1785.78x-141.39x-207.07x-260.67x-94.50x-23.11x-19.65x-18.51x
Total Equity
470.8K▲ 0%
730.08K▲ 55.1%
-156.68K▼ 121.5%
-838.28K▼ 435.0%
10.2M▲ 1316.4%
34.63M▲ 239.6%
24.45M▼ 29.4%
15.52M▼ 36.5%
7.56M▼ 51.3%
5.69M▲ 0%
Equity Growth %
158.13%55.07%-121.46%-435.02%1316.44%239.59%-29.4%-36.53%-51.26%-196.9%
Book Value per Share
0.310.31-0.07-1.546.7512.705.971.631.770.94
Total Shareholders' Equity
470.8K730.08K-156.68K-838.28K10.2M34.63M24.45M15.52M7.56M5.69M
Common Stock
231.56K391.18K405.16K420.66K96.25K40.02K46.78K154.27K69.83K72.66K
Retained Earnings
-1.88M-3.19M-4.77M-6.22M-10.11M-24.12M-37.89M-52.75M-67.52M-69.98M
Treasury Stock
00000000-1.97M0
Accumulated OCI
00005.8K-201.65K-268.85K-409.53K-249.29K-261.73K
Minority Interest
0000000000

AIMD Cash Flow Statement

Ainos, Inc. (AIMD) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-542.7K-1.01M-909.48K-499.55K-1.25M-3.04M-4.69M-5.81M-4.61M-4.37M
Operating CF Margin %
-216.28%-1298.44%-7752.76%-3016.07%-210.23%-86.39%-3844.56%-28020.01%-3716.82%-
Operating CF Growth %
-4.2%-85.96%9.88%45.07%-150.22%-143.26%-54.39%-23.72%20.55%72.04%
Net Income
-617.38K-1.34M-1.58M-1.45M-3.89M-14.01M-13.77M-14.86M-14.77M-13.94M
Depreciation & Amortization
39.99K56.19K22.24K14.7K2.04M4.83M4.85M4.8M4.78M4.78M
Stock-Based Compensation
106.25K100.37K0524.78K150.29K6.42M1.11M3.54M1.73M1.67M
Deferred Taxes
0000000000
Other Non-Cash Items
38.89K27.77K395.04K02.22K02.9M672.96K2.92M2.06M
Working Capital Changes
-110.46K145.12K254.54K411.6K441.72K-289.35K189.8K37.12K728.68K1.06M
Change in Receivables
31.8K-502.01K000-201.55K201.09K3993469
Change in Inventory
-7.97K22.67K-4.13K1.11K3.02K-595.22K221.77K23.84K-151.81K-181.27K
Change in Payables
-9.46K54.84K261.67K419.62K794.17K00000
Cash from Investing
-49.1K-7.28K-13.11K-7.24K-180.52K-630.18K-101.53K-125.29K-2.22K18.29K
Capital Expenditures
-49.1K-7.28K-13.11K-7.24K-143.79K-633.82K-92.98K-21.33K-34.56K-9.46K
CapEx % of Revenue
19.57%9.36%111.73%43.73%24.18%18.01%76.15%102.9%27.84%52.25%
Acquisitions
0000000001.75K
Investments
----------
Other Investing
-49.1K-2.37K00-36.73K3.65K-8.54K-103.96K32.34K26K
Cash from Financing
2.44M254.98K54.97K120K3.15M3.85M4.92M8.03M1.01M4.41M
Debt Issued (Net)
95K0-70.08K120K3.09M2.07M5.31M8.12M-1M1.81M
Equity Issued (Net)
144.36K0125.05K001.78M-30102.01M2.6M
Dividends Paid
0-34.28K00000000
Share Repurchases
000000-3010-2600
Other Financing
2.2M289.26K0064.75K0-390K-97.5K00
Net Change in Cash
1.85M▲ 0%
-761.5K▼ 141.3%
-867.62K▼ 13.9%
-386.79K▲ 55.4%
1.73M▲ 547.1%
101.86K▼ 94.1%
32.27K▼ 68.3%
2.01M▲ 6121.1%
-3.48M▼ 273.1%
213.14K▲ 0%
Free Cash Flow
-591.8K▲ 0%
-1.02M▼ 71.8%
-922.58K▲ 9.2%
-506.79K▲ 45.1%
-1.39M▼ 175.0%
-3.67M▼ 163.6%
-4.79M▼ 30.3%
-5.83M▼ 21.8%
-4.65M▲ 20.2%
-4.38M▲ 0%
FCF Margin %
-235.84%-1307.8%-7864.49%-3059.8%-234.42%-104.4%-3920.71%-28122.91%-3744.66%-24200.77%
FCF Growth %
11.56%-71.76%9.24%45.07%-175.02%-163.64%-30.29%-21.76%20.25%21.57%
FCF per Share
-0.39-0.43-0.43-0.93-0.92-1.35-1.17-0.61-1.09-0.73
FCF Conversion (FCF/Net Income)
0.88x0.75x0.57x0.34x0.32x0.22x0.34x0.39x0.31x0.31x
Interest Paid
00903019.38K43.25K16.9K21.67K320
Taxes Paid
0000008008008000

AIMD Key Ratios

Ainos, Inc. (AIMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
-131.13%-222.94%-551.86%--83.1%-62.49%-46.62%-74.38%-128%-160.55%
Return on Invested Capital (ROIC)
-----47.71%-45.47%-31.66%-39.81%-50.24%-53.78%
Gross Margin
75.96%16.53%25.22%31.91%69.02%39.93%-207.79%-153.73%-3767.2%-26296.83%
Net Margin
-246.04%-1722.3%-13487.2%-8758.21%-654.04%-397.96%-11276.98%-71702.26%-11897.04%-76996.25%
Debt / Equity
1.88x0.70x--0.36x0.04x0.24x0.77x1.45x1.93x
Interest Coverage
-15.41x-336.78x-1785.78x-141.39x-207.07x-260.67x-94.50x-23.11x-19.65x-18.51x
FCF Conversion
0.88x0.75x0.57x0.34x0.32x0.22x0.34x0.39x0.31x0.31x
Revenue Growth
--69.03%-84.91%41.19%3489.71%491.97%-96.53%-83.02%498.95%-82.95%
Related:AIMD Dividend History·AIMD Revenue History·AIMD Price History·AIMD P/E History·AIMD Financial Ratios·AIMD Institutional Holders

AIMD SEC Filings & Documents

Ainos, Inc. (AIMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 13, 2026·SEC

Material company update

Mar 30, 2026·SEC

Material company update

Jan 6, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 30, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Mar 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 13, 2026·SEC

FY 2025

Nov 13, 2025·SEC

FY 2025

Aug 13, 2025·SEC

AIMD Frequently Asked Questions

Ainos, Inc. (AIMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Ainos, Inc. (AIMD) reported $0.0M in revenue for fiscal year 2025. This represents a 97% decrease from $0.7M in 1996.

Ainos, Inc. (AIMD) grew revenue by 499.0% over the past year. This is strong growth.

Ainos, Inc. (AIMD) reported a net loss of $13.9M for fiscal year 2025.

Dividend & Returns

Ainos, Inc. (AIMD) has a return on equity (ROE) of -128.0%. Negative ROE indicates the company is unprofitable.

Ainos, Inc. (AIMD) had negative free cash flow of $4.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in AIMD back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in AIMD be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →